Trusted by healthcare and life sciences
companies worldwide
"We've always been excited by the potential of AI to revolutionise clinical trial payment workflows, but data security and privacy concerns have been a significant roadblock.
Our partnership with Ryght clears the way for us to innovate on solutions like intelligent data validation, which will dramatically boost the accuracy, efficiency, and speed of our payment processes while saving valuable time and effort for sponsors, sites and participants."
Jon Anderson
CEO
nmible
"Ryght's cutting-edge technology aligns perfectly with our vision of using the power and potential of AI to transform healthcare data into novel, actionable insights that help clinicians practice more proactive care that delivers better patient outcomes."
Sean Cassidy
CEO
Lucem Health
"We are thrilled to collaborate with Ryght and utilize their GenAI platform to advance our clinical trial processes. Ryght's innovative technology complements our dedication to innovation and excellence seamlessly. Through the application of AI, we aim to further support our biotech clients to develop transformative therapeutics in areas of unmet need.”
Yvonne Lungershausen
CEO
Avance Clinical
"Ryght's cutting-edge technology aligns perfectly with our commitment to innovation that enables our customers to rapidly identify clinically qualified patients, leading to faster enrollment in clinical trials.
By harnessing the power of AI, we can continue to unlock new insights and accelerate access to clinical research."
Dave Levin
CEO
BEKhealth
Our NIMBC clinical research program greatly benefited from the Ryght platform. As a clinical researcher, I heavily relied on the platform’s literature review applications to delve into cytokine ratios and cytokine diagnostics used in patient treatment. Our scientific team had previously explored this, but not to the extent that the Ryght tool was able to in a brief time. Through Ryght, we could access comprehensive information and gain new perspectives into areas the Ryght tool had newly identified. This is like having a graduate student or research resource dedicated to our project. The Ryght tool identified some cytokine relationships we had not explored and provided a rapid summary with documented literature sources. This saved us valuable time and resources and expanded our knowledge in understanding our PD results. Thanks to Ryght, we were empowered to advance our research efficiently and effectively.
Shane Roberts
Sr. Clinical Research Associate
Surge Therapeutics
"At the University of Adelaide, we are committed to advancing world-class research that addresses many of the challenges faced by society. Our new partnership with Ryght and their cutting-edge AI technology is a testament to this commitment. By working together, we can leverage our collective expertise to develop innovative, responsible and tested solutions for better public health and other critical issues and bring Australia’s AI capabilities up to world-class standards where they belong.”
Professor Mark Hutchinson BSc, PhD
Interim Director of the Institute for Photonics and Advanced Sensing (IPAS)
Adelaide University
Draft Your Key Trial Documents in Half the Time
Leverage pre-built templates and AI-powered guidance or use your company’s document templates to speed through your next ICF or Feasibility questionnaire. Ryght reduces manual work and helps you speed through documents that used to take you days to complete.
Improve Collaboration Between Sites and Sponsors
Ryght's AI copilots are designed to empower Sponsors and CROs to operate more efficiently, collaborate better with Sites, and unlock new revenue opportunities.
Build Next-Generation Apps with GenAI-as-a-Service
Connect Ryght's API-driven platform to your data to integrate our generative AI technology for your users. Not a developer? Contact us to learn how we can help you with custom development.